| Vertex Pharmaceuticals (CH) GmbH - Trikafta 100 mg / 50 mg / 75 mg, 150 mg, Filmtabletten | | 67773 | | 01 | | Trikafta 100 mg / 50 mg / 75 mg, 150 mg | | Filmtabletten | | R07AX32 | | Ivacaftor, Tezacaftor and Elexacaftor | | 10.12.2020 | | |
| | Composition | | Filmtablette Morgendosis (elexacaftorum 100 mg / tezacaftorum 50 mg / ivacaftorum 75 mg): elexacaftorum 100 mg, tezacaftorum 50 mg, ivacaftorum 75 mg, hypromellosum, hypromellosi acetas succinas, natrii laurilsulfas, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, E 171, talcum, E 172 (flavum), E 172 (rubrum) pro compresso obducto corresp. natrium 2.68 mg.
Filmtablette Abenddosis (ivacaftorum 150 mg): ivacaftorum 150 mg, hypromellosi acetas succinas, natrii laurilsulfas, cellulosum microcristallinum, lactosum monohydricum 167.2 mg, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 132, cera carnauba, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum pro compresso obducto corresp. natrium 1.82 mg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Filmtablette Morgendosis (Elexacaftorum 100 mg / Tezacaftorum 50 mg / Ivacaftorum 75 Mg): Elexacaftorum | 100 mg | | Ivacaftorum | 75 mg | | Tezacaftorum | 50 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Elexacaftorum | 100 mg | | Ivacaftorum | 150 mg | | Tezacaftorum | 50 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) pro Compresso Obducto | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosi Acetas Succinas | | | | Hypromellosum | | Überzug | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Talcum | | |
| |
| Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Filmtablette Abenddosis (Ivacaftorum 150 Mg): Ivacaftorum | 150 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Elexacaftorum | 100 mg | | Ivacaftorum | 150 mg | | Tezacaftorum | 50 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | Ammonii Hydroxidum pro Compresso Obducto | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | Cera Carnauba | | | | E 132 | | color. | | E 171 | | color. | | E 172 | | color. | | Hypromellosi Acetas Succinas | | | | Lacca | | Drucktinte | | Lactose Monohydrate | 167.2 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 84 | 13896.18 | 14565.30 | A | LS | Oui |
|
|
